Carrie L. Bourdow's Net Worth

$2.84 Million

Estimate Recalculated Nov 3, 2024 09:37PM EST

Who is Carrie L. Bourdow?

Carrie L. Bourdow has an estimated net worth of $2.84 Million. This is based on reported shares across multiple companies, which include TREVENA INC, Sesen Bio, Inc., Nabriva Therapeutics plc, and Nabriva Therapeutics Plc.

SEC CIK

Carrie L. Bourdow's CIK is 0001638989

Past Insider Trading and Trends

2018 was Carrie L. Bourdow's most active year for acquiring shares with 6 total transactions. Carrie L. Bourdow's most active month to acquire stocks was the month of November. 2023 was Carrie L. Bourdow's most active year for disposing of shares, totalling 4 transactions. Carrie L. Bourdow's most active month to dispose stocks was the month of November. 2023 saw Carrie L. Bourdow paying a total of $286,700.00 for 570,000 shares, this is the most they've acquired in one year. In 2020 Carrie L. Bourdow cashed out on 284,618 shares for a total of $646,082.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TREVENA INC (TRVN) Snapshot price: $3.83

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+257.09%
462.88K
$0.61
$282,354.97
642.92K
Dec 14
Form 4
-6.26%
-12.03K
$0.59
-$7,096.52
180.05K
Dec 2
Form 4
+108.61%
100K
—
—
192.07K
Jan 6
Form 4
-1.44%
-1.34K
$1.55
-$2,080.10
92.07K
Dec 17
Form 4
-3.67%
-3.56K
$3.42
-$12,175.20
93.42K
Dec 2
Form 4
-1.36%
-33.55K
$0.70
-$23,482.20
2.42M
Dec 17
Form 4
-3.67%
-93.56K
$0.65
-$60,814.65
2.46M
Dec 6
Form 4
+96.04%
1.25M
—
—
2.55M
Dec 2
Form 4
+4.51%
56.2K
$1.79
$100,541.80
1.3M
Jun 28
Form 4/A
-10.86%
-151.68K
$2.27
-$344,322.68
1.25M
Dec 7
Form 4
+59.41%
471.1K
—
—
1.26M
Dec 17
Form 4
-14.36%
-132.93K
$2.27
-$301,760.18
792.96K
Dec 7
Form 4
+244.33%
657K
—
—
925.89K
Dec 12
Form 4
-6.21%
-17.80K
$0.69
-$12,265.18
268.89K
Dec 2
Form 4
—
0
—
—
0
Sep 19
Form 4
-5.85%
-17.80K
$1.17
-$20,828.34
286.7K
Jun 3
Form 4
+19.65%
50K
$1.02
$51,000.00
304.5K
Feb 1
Form 4
+5,555.56%
250K
—
—
254.5K
Dec 6
Form 4
—
0
—
—
0
Sep 27
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Aug 28
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Jan 6
Form 4
+800.00%
4K
$4.34
$17,360.00
4.5K
Nov 9
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
May 4
Form 3
—
0
—
—
0
No matching records found

Sesen Bio, Inc. (CARM) Snapshot price: $0.9803

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
40K
—
—
40K
Jun 22
Form 4
—
0
—
—
0
May 3
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
Feb 24
Form 3
—
0
—
—
0
No matching records found

Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.00001

Director

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-46.23%
-8.54K
$0.17
-$1,486.81
9.93K
Aug 1
Form 4
-4.04%
-777.00
$1.20
-$932.40
18.47K
Aug 2
Form 4
+1,000.00%
17.5K
—
—
19.25K
Jul 28
Form 4
∞
17.5K
—
—
17.5K
Jul 29
Form 4
—
0
—
—
0
Jul 31
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jul 31
No matching records found

Nabriva Therapeutics Plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found